Cases 31 - 40 of 85
KPH Healthcare Services, et al v. Mylan, N.V., et al
as 23-3014
Plaintiff / Appellant:
KPH HEALTHCARE SERVICES, INC., individually and on behalf of all others similarly situated, AKA Kinney Drugs, Inc., FWK HOLDINGS, LLC and CESAR CASTILLO, LLC, individually and on behalf of all those similarly situated
Defendant / Appellee:
PFIZER, INC., KING PHARMACEUTICALS, INC., MERIDIAN MEDICAL TECHNOLOGIES, INC. and others
Defendant:
MYLAN ENTITIES
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ACCORD HEALTHCARE, INC. et al
as 1:2023cv00157
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS LTD.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Theravance Biopharma R&D IP, LLC et al v. Lupin Inc. et al
as 1:2023cv00187
Plaintiff:
Theravance Biopharma R&D IP, LLC, Theravance Biopharma Ireland Limited, Theravance Biopharma US, Inc. and others
Defendant:
Lupin Inc., Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mylan Inc. et al v. Medimpact Healthcare Systems, Inc.
as 3:2023cv00213
Plaintiff:
Mylan Inc. and Mylan Specialty L.P.
Defendant:
Medimpact Healthcare Systems, Inc.
Cause Of Action: 28 U.S.C. § 1331 Fed. Question
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mylan N.V., et al v. KPH Healthcare Services, Inc., et al
as 22-604
Petitioner:
MYLAN N.V., MYLAN SPECIALTY L.P. and MYLAN PHARMACEUTICALS INC.
Respondent:
KPH HEALTHCARE SERVICES, INC., AKA Kinney Drugs, Inc., FWK HOLDINGS, LLC and CESAR CASTILLO, LLC, individually and on behalf of all those similarly situated
In re: EpiPen Direct Purchaser Litigation
as 6:2022mc00033
In Re:
In re: EpiPen Direct Purchaser Litigation
Petitioner:
Laurence F. Doud, III
Defendant:
Mylan Inc., Mylan Specialty L.P., Optumrx, Inc. and others
RXC Acquisition Company v. Alkermes, Inc. et al
as 8:2021cv02264
Defendant:
WESLEY CHAPEL RX LLC, CANAL STREET PHARMACY LLC, Brooksville Drugs Inc. and others
Cross Defendant:
NEW CARE PHARMACY LLC, MEDICAL CENTER PHARMACY LLC, TAMPA SPECIALTY PHARMACY LLC and others
Plaintiff:
RXC ACQUISITION COMPANY doing business as RXCROSSROADS BY MCKESSON and RXC Acquisition Company a Delaware corporation doing business as RXCrossroads by Mckesson
Not Classified By Court:
Jonathan C. Koch
Cause Of Action: 28 U.S.C. § 1332 Diversity-(Citizenship)
County of Walker v. OptumRx, Inc. et al
as 1:2019op45713
Defendant:
Abbott Laboratories, Janssen Pharmaceutica Inc., Mylan Specialty, L.P. and others
Plaintiff:
County of Walker
Lacee Lacesa et al v. Walgreen Co. et al
as 2:2022cv02558
Plaintiff:
Lacee Lacesa, Ezra Lacesa, Asher Lacesa and others
Defendant:
Walgreen Co., Mylan Specialty, L.P., Mylan Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal - Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
